Impact of immune checkpoint inhibitors on vision and eye health.
作者信息
Masalkhi Mouayad, Wahoud Noura, Moran Bridget, Elhassadi Ezzat
机构信息
School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
出版信息
Eye (Lond). 2024 Oct;38(15):2854-2856. doi: 10.1038/s41433-024-03212-z. Epub 2024 Jul 3.
Abstract
摘要
相似文献
1
Impact of immune checkpoint inhibitors on vision and eye health.
Eye (Lond). 2024 Oct;38(15):2854-2856. doi: 10.1038/s41433-024-03212-z. Epub 2024 Jul 3.
2
Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy.
Thorac Cancer. 2020 Mar;11(3):810-818. doi: 10.1111/1759-7714.13327. Epub 2020 Feb 4.
3
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.
Lancet Oncol. 2024 Aug;25(8):1053-1069. doi: 10.1016/S1470-2045(24)00278-X. Epub 2024 Jul 15.
4
[Effects of pesticides on eye and vision].
Arh Hig Rada Toksikol. 1976;27(4):321-33.
5
[Ocular physiopathology of digitalis intoxication].
Rev Otoneuroophtalmol. 1978 May-Jun;50(3):257-68.
6
Blurred vision and systemic medication.
J Med Assoc Ga. 1966 Jan;55(1):8-9.
7
[Drug-induced ocular side effects--an overview].
Lakartidningen. 1986 May 7;83(19):1762-70.
8
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience.
J Cancer Res Clin Oncol. 2021 Sep;147(9):2789-2800. doi: 10.1007/s00432-021-03610-w. Epub 2021 Mar 28.
9
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data.
Immunotherapy. 2025 Mar;17(4):257-268. doi: 10.1080/1750743X.2025.2485012. Epub 2025 Apr 4.
10
TAM kinase inhibition and immune checkpoint blockade- a winning combination in cancer treatment?
Expert Opin Ther Targets. 2021 Feb;25(2):141-151. doi: 10.1080/14728222.2021.1869212. Epub 2020 Dec 31.
引用本文的文献
1
Arteritic anterior ischemic optic neuropathy secondary to immune checkpoint inhibitors: A case report.
Radiol Case Rep. 2025 Jun 30;20(9):4774-4777. doi: 10.1016/j.radcr.2025.06.014. eCollection 2025 Sep.
2
Ethical Considerations of Neuralink and Brain-Computer Interfaces.
Ann Biomed Eng. 2024 Aug;52(8):1937-1939. doi: 10.1007/s10439-024-03511-2. Epub 2024 Apr 11.
3
Concerns with OpenAI's Sora in Medicine.
Ann Biomed Eng. 2024 Aug;52(8):1932-1934. doi: 10.1007/s10439-024-03505-0. Epub 2024 Apr 1.
本文引用的文献
1
Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions.
Front Ophthalmol (Lausanne). 2022 Nov 18;2:1044904. doi: 10.3389/fopht.2022.1044904. eCollection 2022.
2
Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review.
Diagnostics (Basel). 2024 Feb 4;14(3):336. doi: 10.3390/diagnostics14030336.
3
Ocular adverse events associated with immune checkpoint inhibitors, a scoping review.
J Ophthalmic Inflamm Infect. 2023 Feb 22;13(1):5. doi: 10.1186/s12348-022-00321-2.
4
Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management.
Int J Ophthalmol. 2022 Apr 18;15(4):646-656. doi: 10.18240/ijo.2022.04.19. eCollection 2022.
5
Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management.
Kidney Med. 2021 Oct 8;3(6):1074-1081. doi: 10.1016/j.xkme.2021.08.008. eCollection 2021 Nov-Dec.
6
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review.
Cancers (Basel). 2021 Oct 18;13(20):5218. doi: 10.3390/cancers13205218.
7
Neurological complications of cancer immunotherapy.
Cancer Treat Rev. 2021 Jun;97:102189. doi: 10.1016/j.ctrv.2021.102189. Epub 2021 Mar 23.
8
Ocular surface disease associated with immune checkpoint inhibitor therapy.
Ocul Surf. 2021 Apr;20:115-129. doi: 10.1016/j.jtos.2021.02.004. Epub 2021 Feb 19.
9
Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience.
Br J Ophthalmol. 2021 Sep;105(9):1263-1271. doi: 10.1136/bjophthalmol-2020-316970. Epub 2020 Aug 23.
10
Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance Analysis.
Ocul Immunol Inflamm. 2022 Jan 2;30(1):191-197. doi: 10.1080/09273948.2020.1773867. Epub 2020 Aug 4.
Zotero 插件